University of Nebraska Medical Center

Wasim Nasser, PhD

Associate Professor, UNMC Department of Biochemistry and Molecular Biology
Research focus: Pathogenesis of breast cancer to brain metastasis and small cell lung cancer


Wasim Nasser

Research interests in Dr. Nasser's lab include unfurling of the basic biology behind the pathogenesis of breast cancer to brain metastasis (BrM) and small cell lung cancer (SCLC). The lab is using ex-vivo organoids and mouse models to understand the role of non-coding RNAs, immunology, metabolism, mitochondrial dynamics and tumor microenvironment in tumor initiation, progression, plasticity, and therapy resistance. Dr. Nasser's team is striving to develop novel and innovative therapies that can be employed for clinical management of BrM and recalcitrant SCLC patients.

If you are interested in contributing to alleviate the agony of BrM and SCLC patients, the Nasser lab will be most happy to host you. Dr. Nasser is currently accepting applications from passionate and enthusiastic summer undergraduate students, graduate students, and postdocs. Please email wasim.nasser@unmc.edu with your CV and a cover letter highlighting your research interest.

Diversity and Inclusion

Dr. Nasser's lab is committed to UNMC defined core principles of maintaining a safe and inclusive environment for everyone, irrespective of race, age, gender, gender identity, sexual orientation, religion, nationality, ethnicity, socio-economic status, ability as well as cultural, political, or other affiliations. This lab is committed in promoting a respectful lab environment and being transparent in our work. Dr. Nasser's team believes that open, honest communication, professionalism in science, and a diverse workforce allows creation of new ideas and service to mankind.

  • PhD, Jamia Hamdard (Hamdard University), New Delhi, India, 2002
Post-Doctoral Training
  • Meharry Medical College (Nashville, TN): 2002-2004
  • North Carolina Central University (Durham, NC): 2004-2007
  • The Ohio State University Medical Center (Columbus, OH): 2007-2011 
Current Funding
  1. NIH/NCI/R01
    Targeting MUC5AC mucin in breast cancer brain metastasis.
    02/01/2021 - 01/31/2026
  1. NIH/NCI/R01
    Novel approach to attenuate small cell lung cancer progression and metastasis.
    7/5/2018 - 6/30/2023
A researcher wearing gloves uses lab equipment

Current Projects

Using state of the art technologies, we are trying to establish novel roles of mucins and other proteins in brain metastasis.